ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 38 filers reported holding ESSA PHARMA INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,101,585 | +14.4% | 356,500 | 0.0% | 0.12% | +17.8% |
| Q2 2023 | $962,550 | -8.5% | 356,500 | 0.0% | 0.10% | -12.2% |
| Q1 2023 | $1,051,675 | +11.3% | 356,500 | -4.9% | 0.12% | +16.2% |
| Q4 2022 | $945,000 | -30.0% | 375,000 | 0.0% | 0.10% | -29.8% |
| Q3 2022 | $1,350,000 | +14.3% | 375,000 | 0.0% | 0.14% | +5.2% |
| Q2 2022 | $1,181,000 | -53.5% | 375,000 | -8.7% | 0.13% | -46.6% |
| Q1 2022 | $2,540,000 | -57.1% | 410,923 | -2.2% | 0.25% | -36.3% |
| Q4 2021 | $5,926,000 | +23.5% | 420,000 | -30.0% | 0.39% | +16.9% |
| Q3 2021 | $4,800,000 | -35.4% | 600,000 | +130.8% | 0.34% | -33.1% |
| Q2 2021 | $7,428,000 | -1.7% | 260,000 | 0.0% | 0.50% | -4.4% |
| Q1 2021 | $7,553,000 | +304.1% | 260,000 | +65.9% | 0.53% | +246.7% |
| Q4 2020 | $1,869,000 | – | 156,700 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |